Ushbu ish iqtibos qilgan ishlar

161 ta ish

Ish: Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3
Sharh maqola20223 iqtibos
ABI
Therapeutic effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaliplatin on ovarian cancer cell line
Zahra Hashempour, Mehdi Noraddini, Majid Nejati +5
Maqola20253 iqtibos
ABI
Cancer stem cells and their niche in cancer progression and therapy
Qiuping Liu, Zongliang Guo, Guoyin Li +5
Sharh maqola20233 iqtibos
ABI
Programmed cell death and melatonin: A comprehensive review
Mahdi Rafiyian, Rüssel J. Reiter, Sayyed Mehdi Rasooli Manesh +5
Sharh maqola20243 iqtibos
ABI
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey, Daofeng Liu, Gengwen Tian +10
Maqola20143 iqtibos
ABI
Metabostemness: A New Cancer Hallmark
Javier A. Menéndez, TomÃ¡s AlarcÃ n
Sharh maqola20143 iqtibos
ABI
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Sharh maqola20133 iqtibos
ABI
Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates
Daniela Hirsch, Thomas Ried
Boshqa20163 iqtibos
ABI
Cancer stem cells revisited
Eduard Batlle, Hans Clevers
Sharh maqola20173 iqtibos
ABI
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Sharh maqola20183 iqtibos
ABI
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. Alhabbab
Sharh maqola20203 iqtibos
ABI
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma
Sylvain Simon, Stanley R. Riddell
Boshqa20203 iqtibos
ABI
Ferroptosis: molecular mechanisms and health implications
Daolin Tang, Xin Chen, Rui Kang +1
Sharh maqola20203 iqtibos
ABI
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity
John P. Murad, Dileshni Tilakawardane, Anthony K. Park +15
Maqola20213 iqtibos
ABI
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yu-Huan Yang, Jiawei Liu, Lü Chen +1
Sharh maqola20223 iqtibos
ABI
Cancer cell targeting by CAR-T cells: A matter of stemness
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane +10
Sharh maqola20223 iqtibos
ABI
Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review
Gianna Di Sario, Valeria Rossella, Elvira Smeralda Famulari +4
Sharh maqola20233 iqtibos
ABI
Single-cell-guided identification of logic-gated antigen combinations for designing effective and safe CAR therapy
Sanna Madan, Tiangen Chang, Alexandra R. Harris +15
Preprint20253 iqtibos
ABI
Precision sniper for solid tumors: CAR-NK cell therapy
Sisi Li, Jiajie Jing, Yueming Chen +6
Sharh maqola20253 iqtibos
ABI
Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
Meng Zhang, Xin Jin, Rui Sun +4
Sharh maqola20212 iqtibos
ABI
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Lingfeng Zhu, Jin Chen
Sharh maqola20232 iqtibos
ABI
Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implications
Ting Wu, Ying‐Qi Zhao, Xinming Zhang +14
Sharh maqola20252 iqtibos
ABI
Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
Hongwen Li, Wenting Song, Zhaoming Li +1
Sharh maqola20222 iqtibos
ABI
VEGF‐FGF Signaling Activates Quiescent CD63<sup>+</sup> Liver Stem Cells to Proliferate and Differentiate
Fei Chen, Kunshan Zhang, Minjun Wang +12
Maqola20242 iqtibos
ABI
Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of β-catenin
Jin Yan, Heyuan Liu, Wenguang Yang +6
Maqola20252 iqtibos
ABI